Page last updated: 2024-10-25

deferoxamine and African Lymphoma

deferoxamine has been researched along with African Lymphoma in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
" We hypothesize that the relatively higher bioavailability of nontransferrin iron in LIT cells, over that in HID cells, determines the differing responses observed under low-iron conditions."1.30The inability of cells to grow in low iron correlates with increasing activity of their iron regulatory protein (IRP). ( Kovár, J; Kriegerbecková, K; Kühn, LC; Musílková, J; Richardson, V; Seiser, C, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kovár, J1
Kühn, LC1
Richardson, V1
Seiser, C1
Kriegerbecková, K1
Musílková, J1

Other Studies

1 other study available for deferoxamine and African Lymphoma

ArticleYear
The inability of cells to grow in low iron correlates with increasing activity of their iron regulatory protein (IRP).
    In vitro cellular & developmental biology. Animal, 1997, Volume: 33, Issue:8

    Topics: Biological Transport; Burkitt Lymphoma; Cell Division; Culture Media; Deferoxamine; HeLa Cells; Huma

1997